We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Device Assists Laparoscopic Surgeons

By HospiMedica staff writers
Posted on 26 Mar 2007
A new pneumoperitoneum creation-assist device (PCAD), allows the surgeon alone to effortlessly and rapidly elevate the abdominal wall away from the underlying critical anatomic structures before or during Veress needle passage.

The Aragon Surgical (Palo Alto, CA, USA) LapCap laparoscopy assist device (LapCap) allows a surgeon to more easily, rapidly, and predictably pass a Veress needle during laparoscopy into the peritoneal cavity in order to create a pneumoperitoneum (the gas-filled space in which the surgeon operates). More...
Utilizing vacuum, the LapCap safely elevates a portion of abdominal wall up and away from the underlying intestines and blood vessels in only 4-8 seconds, creating a pathway for blind Veress needle passage and reducing the surgeon's anxiety over this initial maneuver. The LapCap is a product of Aragon Surgical and has been approved by the U.S. Food and Drug Administration (FDA).

"We are extremely excited to be adding the breakthrough LapCap technology to the products already under development here at Aragon Surgical,” said Dr. Peter Edelstein, president and CEO of Aragon Surgical. "Having performed numerous laparoscopic operations myself, I have no doubt that the LapCap will be of great benefit to my colleagues at the start of their laparoscopic procedures.”

Laparoscopic gynecologists, general surgeons, bariatric surgeons, colon and rectal surgeons, and urologists create a pneumoperitoneum approximately 2.4 million times a year in the United States. Currently, the surgeon (often assisted by a nurse), must forcefully lift the abdominal wall using penetrating clamps while simultaneously attempting to safely pass the 12-cm Veress needle blindly into the abdomen.

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.